Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy (OPTI-PP)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Hospitalization

Treatments

Other: Pharm Tech participates in department
Other: One month of department-wide observation

Study type

Interventional

Funder types

Other

Identifiers

NCT02614638
2015-A01309-40 (Other Identifier)
LOCAL/2015/GL-01

Details and patient eligibility

About

The main objective of this study is to evaluate the impact of the presence of a pharmacy technician in a care unit (Hepato-Gastroenterology Department) on detected medication errors. This is a before-after study consisting of three sequential phases: Month 1: one month of observation of what is happening in the department Month 2: one month wash out period Month 3: active participation of a pharmacy technician in the department

Full description

The secondary objectives of this study are: A- To assess the impact of the presence of a pharmacy technician on the ratio of the number of patients with at least one medication error / number of included patients hospitalized in the service. B- To characterize detected medication errors. C- To identify and evaluate the potential causes of medication errors. D- To evaluate whether the presence of a pharmacy technician reduces nursing time spent on medication management. E- To evaluate the economic impact of the presence of a pharmacy technician. F- To evaluate the acceptability of the intervention by the nursing staff and pharmacy technicians using questionnaires.

Enrollment

129 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is hospitalized in the Hepato-Gastroenterology Department of the Nîmes University Hospital

Exclusion criteria

  • The patient is under judicial protection
  • The patient, or his/her legal guardian, expresses opposition to participation in the study
  • It is impossible to correctly inform the patient

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

129 participants in 2 patient groups

1st observational period (before experimental intervention)
Active Comparator group
Description:
Patients in this arm are included during a first month of observation before the intervention is implemented. Intervention: One month of department-wide observation
Treatment:
Other: One month of department-wide observation
2nd obs. period (during experimental intervention)
Experimental group
Description:
Following a one-month wash-out period, patients in this arm are included during a second month of observation during which the intervention is implemented. Intervention: Pharm Tech participates in department
Treatment:
Other: Pharm Tech participates in department

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems